Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Transcranial Photobiomodulation (tPBM) for Individuals With Autism Spectrum Disorder and Epileptiform Activity
Conditions
Interventions
noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM)
Locations
1
United States
Rossignol Medical Center
Phoenix, Arizona, United States
Start Date
July 1, 2024
Primary Completion Date
February 10, 2026
Completion Date
February 10, 2026
Last Updated
April 24, 2026
NCT07439276
NCT06315322
NCT07421830
NCT05066178
NCT05501678
NCT06700356
Lead Sponsor
Richard Frye
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions